Quezon, Simiona T.

HRN: 22-82-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/09/2023
04/15/2023
IV
500mg
Q8h
Ameobiasis
Waiting Final Action 
04/12/2023
METRONIDAZOLE 500MG (TAB)
04/12/2023
04/15/2023
ORAL
500mg
Tid
Ameobiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: